Interleukin-1 receptor antagonist gene in multiple sclerosis. 1997

G Semana, and J Yaouanq, and M Alizadeh, and M Clanet, and G Edan

UI MeSH Term Description Entries
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D017472 Receptors, Interleukin-1 Cell surface receptors that are specific for INTERLEUKIN-1. Included under this heading are signaling receptors, non-signaling receptors and accessory proteins required for receptor signaling. Signaling from interleukin-1 receptors occurs via interaction with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88. IL-1 Receptor,IL-1 Receptors,IL1 Receptor,Interleukin-1 Receptor,Interleukin-1 Receptors,Receptor, Interleukin-1,Receptors, IL-1,IL1 Receptors,Interleukin 1 Receptor,IL 1 Receptor,IL 1 Receptors,Interleukin 1 Receptors,Receptor, IL-1,Receptor, IL1,Receptor, Interleukin 1,Receptors, IL 1,Receptors, IL1,Receptors, Interleukin 1

Related Publications

G Semana, and J Yaouanq, and M Alizadeh, and M Clanet, and G Edan
October 1995, Lancet (London, England),
G Semana, and J Yaouanq, and M Alizadeh, and M Clanet, and G Edan
June 2000, Journal of neuroimmunology,
G Semana, and J Yaouanq, and M Alizadeh, and M Clanet, and G Edan
February 1997, Journal of neurology, neurosurgery, and psychiatry,
G Semana, and J Yaouanq, and M Alizadeh, and M Clanet, and G Edan
July 1996, Journal of neuroimmunology,
G Semana, and J Yaouanq, and M Alizadeh, and M Clanet, and G Edan
June 2010, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,
G Semana, and J Yaouanq, and M Alizadeh, and M Clanet, and G Edan
January 2020, Endocrine, metabolic & immune disorders drug targets,
G Semana, and J Yaouanq, and M Alizadeh, and M Clanet, and G Edan
November 2007, Leukemia & lymphoma,
G Semana, and J Yaouanq, and M Alizadeh, and M Clanet, and G Edan
October 2020, European journal of neurology,
G Semana, and J Yaouanq, and M Alizadeh, and M Clanet, and G Edan
August 2009, Clinical & experimental ophthalmology,
G Semana, and J Yaouanq, and M Alizadeh, and M Clanet, and G Edan
June 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!